Loading...
Myomo, Inc. reported a 6% increase in revenue for the fourth quarter of 2021, reaching $4.0 million. The company's gross margin also improved to 77.4%.
Revenue was $4.0 million, up 6% as the Company successfully managed reimbursement and supply chain challenges during the quarter
Gross margin was 77.4%, up 400 basis points
Backlog increased 18% to 154 units
The reimbursement pipeline as of December 31, 2021 consisted of 808 MyoPro candidates
Myomo expects to generate continued year-over-year revenue growth for 2022. For the first quarter, the company expects product revenue to be in the range of $2.6 million to $3.0 million, an increase of 11% to 28% over the prior-year quarter.